Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Quinapril and lipoic acid show benefit in metabolic syndrome

April 8, 2010

Galapagos identifies novel androgen receptor ligands

April 8, 2010

Warner Chilcott assumes full commercial responsibility for Actonel in U.S.

April 7, 2010

Teijin and Astellas to market TMX-67 for hyperuricemia in gout patients in China and Hong Kong

April 7, 2010

FDA's metabolic division deems Repros' phase II Androxal trial protocol adequate

April 7, 2010

Effects of dalcetrapib and pravastatin on lipoprotein profile determined in dyslipidemia

April 7, 2010

AMAG and Takeda enter into agreement to develop and market Feraheme

April 6, 2010

Orexigen submits NDA in U.S. for Contrave obesity treatment

April 6, 2010

Ardea reports phase IIb RDEA-594 monotherapy data in hyperuricemia and gout

April 6, 2010

Merck & Co. selects antiobesity CB1 inverse agonist MK-5596 as clinical candidate

April 6, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 16, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Voyager’s gene therapy reduces tau levels in AD models
BioWorld Science
At the Alzheimer’s Association International Conference, researchers from Voyager Therapeutics Inc. presented preclinical efficacy data for VY-1706, a blood-brain...